Every possible candidate was explored, and AstraZeneca was one of them. Our current option is to get it through COVAX.
Perhaps Mark or Roger could speak further to the AstraZeneca option.
On February 18th, 2021. See this statement in context.
On February 18th, 2021. See this statement in context.
February 18th, 2021 / 11:20 a.m.
Co-Chair, COVID-19 Vaccine Task Force
Every possible candidate was explored, and AstraZeneca was one of them. Our current option is to get it through COVAX.
Perhaps Mark or Roger could speak further to the AstraZeneca option.
See context to find out what was said next.